Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
04 2020
Historique:
received: 24 09 2019
accepted: 31 12 2019
pubmed: 29 1 2020
medline: 15 12 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

Coronary artery disease (CAD) is a major challenge in patients with type 2 diabetes (T2D). Coronary computed tomography angiography (CCTA) provides a detailed anatomic map of the coronary circulation. Proteomics are increasingly used to improve diagnostic and therapeutic algorithms. We hypothesized that the protein panel is differentially associated with T2D and CAD. In CAPIRE (Coronary Atherosclerosis in Outlier Subjects: Protective and Novel Individual Risk Factors Evaluation-a cohort of 528 individuals with no previous cardiovascular event undergoing CCTA), participants were grouped into CAD Though CAD We concluded that

Identifiants

pubmed: 31988066
pii: dc19-1902
doi: 10.2337/dc19-1902
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

843-851

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 by the American Diabetes Association.

Auteurs

Giulia Ferrannini (G)

Department of Medical Sciences, Postgraduate School of Internal Medicine, University of Turin, Turin, Italy.
Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Maria Laura Manca (ML)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Marco Magnoni (M)

IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.

Felicita Andreotti (F)

Institute of Cardiology, FPG IRCCS, Catholic University Medical School, Rome, Italy.

Daniele Andreini (D)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Cardiovascular Section, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Roberto Latini (R)

Mario Negri Institute of Pharmacological Research-IRCCS, Milan, Italy.

Attilio Maseri (A)

Heart Care Foundation, Florence, Italy.

Aldo P Maggioni (AP)

ANMCO Research Center, Heart Care Foundation, Florence, Italy.

Rachel M Ostroff (RM)

Clinical Research and Development, SomaLogic Inc., Boulder, CO.

Stephen A Williams (SA)

Clinical Research and Development, SomaLogic Inc., Boulder, CO.

Ele Ferrannini (E)

CNR Institute of Clinical Physiology, Pisa, Italy ferranni@ifc.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH